Article info

other Versions

Download PDFPDF
Regulation of the KATP-JNK gap junction signaling pathway by immunomodulator astragaloside IV attenuates neuropathic pain

Authors

  1. Correspondence to Dr Wen-Tao Liu, Pharmacology, Nanjing Medical University, Nanjing, China; painresearch{at}njmu.edu.cn; Dr Hang Xiao; hxiao{at}njmu.edu.cn; Professor Ji-Hua Liu; liujihua{at}cpu.edu.cn
View Full Text

Citation

Dai W, Zhang L, Han L, et al
Regulation of the KATP-JNK gap junction signaling pathway by immunomodulator astragaloside IV attenuates neuropathic pain

Publication history

  • Received February 21, 2020
  • Revision received July 29, 2020
  • Accepted August 3, 2020
  • First published September 22, 2020.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.